PAM
PFE icon

Parvin Asset Management’s Pfizer PFE Stock Holding History

Parvin Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6K Buy
2,100
+800
+62% +$20.9K 0.04% 217
2026
Q1 		$36.5K Hold
1,300
– – 0.03% 225
2025
Q4 		$32.4K Buy
1,300
+1,000
+333% +$25.2K 0.03% 226
2025
Q3 		$7.64K Sell
300
-100
-25% -$2.47K 0.01% 263
2025
Q2 		$9.7K Hold
400
– – 0.01% 266
2025
Q1 		$10.1K Hold
400
– – 0.01% 259
2024
Q4 		$10.6K Buy
+400
New +$10.8K 0.01% 255

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parvin Asset Management's PFE Position: Q2 2026 in Review

Parvin Asset Management increased its Pfizer (PFE) stake by 62% in Q2 2026, buying an estimated $20.9K and bringing the position to 2,100 shares worth $50.6K. The position accounts for 0.04% of the portfolio, ranked #217.

Parvin Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Parvin Asset Management held 2,100 shares of Pfizer worth $50.6K as of Q2 2026.
  • Parvin Asset Management bought 800 Pfizer shares in Q2 2026, an estimated $20.9K.
  • Pfizer made up 0.04% of Parvin Asset Management's portfolio in Q2 2026, its #217 holding.
  • Parvin Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.